1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor ActivityMILLER-MOSLIN, Karen; PEUKERT, Stefan; MIAO DAI et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 13, pp 3954-3968, issn 0022-2623, 15 p.Article

Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats. CommentaryCAREY, Robert M; FELDMAN, David L; MANIARA, Wieslawa et al.Hypertension (Dallas, Tex. 1979). 2008, Vol 52, Num 1, issn 0194-911X, 63-64, 130-136 [9 p.]Article

Pharmacodynamic behaviour of the selective cyclooxygenase-2 inhibitor lumiracoxib in the lipopolysaccharide-stimulated rat air pouch modelESSER, Ronald E; MISERENDINO-MOLTENI, Rocca; SHARR, Michele et al.European journal of pharmaceutical sciences. 2005, Vol 25, Num 1, pp 25-30, issn 0928-0987, 6 p.Article

Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 DiabetesBEBERNITZ, Gregory R; BEAULIEU, Valerie; KIRMAN, Louise C et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 19, pp 6142-6152, issn 0022-2623, 11 p.Article

Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseAICHER, Thomas D; ANDERSON, Robert C; KAPLAN, Emma L et al.Journal of medicinal chemistry (Print). 2000, Vol 43, Num 2, pp 236-249, issn 0022-2623Article